Literature DB >> 3807265

Posttransfusion purpura. A survey of 13 cases.

C Mueller-Eckhardt, V Kiefel, G Mueller-Eckhardt, R Bambauer, J Baur, B Behringhoff, U Deuss, D Heinrich, H O Klein, K Lechner.   

Abstract

Thirteen cases of posttransfusion purpura (PTP) which were diagnosed in Germany and Austria from 1977-1985 are described. All patients were women with a mean age of 58.6 years (range, 36-77 years). All but one had been pregnant and received blood transfusions 2 to 12 days prior to the onset of PTP. The thrombocytopenic purpura was always severe with a nadir of platelet counts below 10 X 10(9)/l and lasted between 3 and 60 days. All patients recovered from PTP. Optimal therapy consisted of administration of high-dose IgG. Twelve of the 13 patients had developed platelet-specific Zwa antibodies (eight of them together with HLA antibodies), in one Zwa positive individual only HLA antibodies were detectable. Five of six HLA-DR typed patients carried DR3 which is considered an immunogenetic risk factor in PTP. Clinical awareness of this rare, but serious iatrogenic transfusion complication is prerequisite for prompt diagnosis and improved therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3807265     DOI: 10.1007/bf01728461

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  23 in total

1.  IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".

Authors:  N R Shulman; R H Aster; A Leitner; M C Hiller
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

2.  Studies on the platelet radioactive anti-immunoglobulin test.

Authors:  C Mueller-Eckhardt; G Schulz; K H Sauer; C Dienst; I Mahn
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells.

Authors:  A Salama; C Mueller-Eckhardt
Journal:  Transfusion       Date:  1984 May-Jun       Impact factor: 3.157

4.  An immune response gene linked to MHC in man.

Authors:  M F Reznikoff-Etievant; J Y Muller; F Julien; C Patereau
Journal:  Tissue Antigens       Date:  1983-10

5.  High-dose intravenous immunoglobulin for post-transfusion purpura.

Authors:  T Becker; S Panzer; D Maas; V Kiefel; R Sprenger; M Kirschbaum; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

6.  Post-transfusion purpura: a serological and immunochemical study.

Authors:  J G Pegels; E C Bruynes; C P Engelfriet; A E von dem Borne
Journal:  Br J Haematol       Date:  1981-12       Impact factor: 6.998

7.  Post-transfusion purpura responding to high dose intravenous IgG: further observations on pathogenesis.

Authors:  S I Berney; P Metcalfe; N C Wathen; A H Waters
Journal:  Br J Haematol       Date:  1985-12       Impact factor: 6.998

8.  [The syndrome of post-transfusion purpura].

Authors:  E Küenzlen; J Bauer; B Behringhoff; J Ettinger; C Mueller-Eckhardt
Journal:  Dtsch Med Wochenschr       Date:  1983-04-29       Impact factor: 0.628

9.  Posttransfusion purpura. Report of a case with anti-P1A1 masked by HLA antibodies.

Authors:  R A Dunstan; W F Rosse
Journal:  Transfusion       Date:  1985 May-Jun       Impact factor: 3.157

10.  Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka.

Authors:  R M Keimowitz; J Collins; K Davis; R H Aster
Journal:  Am J Hematol       Date:  1986-01       Impact factor: 10.047

View more
  1 in total

Review 1.  High-dose IgG for post-transfusion purpura-revisited.

Authors:  C Mueller-Eckhardt; V Kiefel
Journal:  Blut       Date:  1988-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.